Your browser doesn't support javascript.
loading
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?
Petit, Bastien; Soudet, Simon; Poenou, Géraldine; Zarrat, Emma; Accassat, Sandrine; Plaisance, Ludovic; Helfer, Hélène; Mismetti, Valentine; Hello, Claire Le; Sevestre, Marie-Antoinette; Mahé, Isabelle; Bertoletti, Laurent.
Affiliation
  • Petit B; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France.
  • Soudet S; Vascular Medicine Department, CHU-Amiens-Picardie, France; EA7516 CHIMERE, University of Picardie Jules Verne, Amiens, France.
  • Poenou G; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France; Internal Medicine Department, Louis-Mourier Hospital, Assistance publique-Hôpitaux de Paris (AP-HP), Colombes, France; Paris Cité University, Paris, France; Université Jean Monnet Saint-Étienne, CHU Saint-Étienne
  • Zarrat E; Vascular Medicine Department, CHU-Amiens-Picardie, France.
  • Accassat S; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France.
  • Plaisance L; Internal Medicine Department, Louis-Mourier Hospital, Assistance publique-Hôpitaux de Paris (AP-HP), Colombes, France.
  • Helfer H; Internal Medicine Department, Louis-Mourier Hospital, Assistance publique-Hôpitaux de Paris (AP-HP), Colombes, France; INSERM, UMR_ S1140 Innovative Therapies in Haemostasis, 75006 Paris, France.
  • Mismetti V; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France; Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, all in F-42055, Saint-Etienne, France.
  • Hello CL; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France; Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, all in F-42055, Saint-Etienne, France.
  • Sevestre MA; Vascular Medicine Department, CHU-Amiens-Picardie, France; EA7516 CHIMERE, University of Picardie Jules Verne, Amiens, France.
  • Mahé I; Internal Medicine Department, Louis-Mourier Hospital, Assistance publique-Hôpitaux de Paris (AP-HP), Colombes, France; Paris Cité University, Paris, France; INSERM, UMR_ S1140 Innovative Therapies in Haemostasis, 75006 Paris, France.
  • Bertoletti L; Vascular Medicine and Therapeutic Department, CHU-Saint-Etienne, Saint-Etienne, France; Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, all in F-42055, Saint-Etienne, France; INSERM, CIC 1408, F-42055, Saint-Etienne, France. Electronic address:
Respir Med Res ; 85: 101069, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38141577
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Randomized Controlled Trials as Topic / Anticoagulants / Neoplasms Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Respir Med Res Year: 2024 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Randomized Controlled Trials as Topic / Anticoagulants / Neoplasms Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Respir Med Res Year: 2024 Document type: Article Affiliation country: France Country of publication: France